Prestwick3_000199

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

30 API Suppliers, 6 USDMF, 3 CEP/COS, 1 JDMF, 8 EU WC, 10 NDC API, 22 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports

DOSSIERs // Finished Dosage Formulations

37 Dossiers, 10 FDA Orange Book, 12 Europe, 3 Canada, 4 South Africa, 8 Listed Dossiers

RELATED EXCIPIENT COMPANIES

Suppliers, 18 BASF, 6 Nanjing Well Pharmaceutical, 6 Kerry, 4 Actylis, 4 Corel Pharma Chem, 3 Gangwal Chemicals, 2 Seppic, 2 Lubrizol Life Science Health, 2 Seqens, 2 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Clariant, 1 SPI Pharma, 1 Finar

EXCIPIENTS BY APPLICATIONS

24 Topical, 17 Solubilizers, 10 Thickeners and Stabilizers, 7 Parenteral, 6 Controlled & Modified Release, 6 Co-Processed Excipients, 5 Emulsifying Agents, 4 Granulation, 4 Direct Compression, 3 Coating Systems & Additives, 3 Film Formers & Plasticizers, 2 Lubricants & Glidants, 2 Taste Masking, 1 Rheology Modifiers, 1 Chewable & Orodispersible Aids, 1 API Stability Enhancers

GLOBAL SALES INFORMATION

9 Finished Drug Prices

9 Finished Drug Prices

MARKET PLACE

8 APIs, 1 DOSSIERS // FDF

ANALYTICAL SOLUTION(s)

3 EDQM Standards, 3 USP Standards, 5 Other Ref. Standards

DIGITAL CONTENT

7 News

7 News

Full Screen View

Regent Pacific

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Regent Pacific's Strategic Partner Receives Approval from NMPA to Submit IND Application

Details:

Under the License Agreement Regent Pacific is now entitled to receive a payment of approximately HK$6.24 million from Wanbang Pharmaceutical, which is payable within 30 business days. NMPA will now formally review Senstend™ for Clinical Trial Approval.

Lead Product(s): Lidocaine,Prilocaine

Therapeutic Area: Psychiatry/Psychology Product Name: Senstend

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Wanbang Biopharmaceuticals

Deal Size: $4.0 million Upfront Cash: Undisclosed

Deal Type: Licensing Agreement December 02, 2020

ASK
US

Upload
your Marketing & Sales content

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Find Drugs in Development News & Deals for Prestwick3_000199

Prestwick3_000199

Prestwick3_000199

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

30 API Suppliers

6 USDMF

3 CEP/COS

1 JDMF

8 EU WC

10 NDC API

22 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

DOSSIERs // Finished Dosage Formulations

37 Dossiers

10 FDA Orange Book

12 Europe

3 Canada

4 South Africa

8 Listed Dossiers

RELATED EXCIPIENT COMPANIES

Suppliers

18 BASF

6 Nanjing Well Pharmaceutical

6 Kerry

4 Actylis

4 Corel Pharma Chem

3 Gangwal Chemicals

2 Seppic

2 Lubrizol Life Science Health

2 Seqens

2 Nanjing Bold Chemical

2 Nomisma Healthcare

1 Clariant

1 SPI Pharma

1 Finar

EXCIPIENTS BY APPLICATIONS

24 Topical

17 Solubilizers

10 Thickeners and Stabilizers

7 Parenteral

6 Controlled & Modified Release

6 Co-Processed Excipients

5 Emulsifying Agents

4 Granulation

4 Direct Compression

3 Coating Systems & Additives

3 Film Formers & Plasticizers

2 Lubricants & Glidants

2 Taste Masking

1 Rheology Modifiers

1 Chewable & Orodispersible Aids

1 API Stability Enhancers

GLOBAL SALES INFORMATION

9 Finished Drug Prices

MARKET PLACE

8 APIs

1 DOSSIERS // FDF

ANALYTICAL SOLUTION(s)

3 EDQM Standards

3 USP Standards

5 Other Ref. Standards

DIGITAL CONTENT

7 News

API SUPPLIERS

API REF. PRICE (USD / KG)

INTERMEDIATES

DOSSIERS // FDF

GLOBAL SALES (USD Million)

EXCIPIENTS

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

REF STANDARD